封面
市场调查报告书
商品编码
1708914

脂肪酰胺市场按产品类型、形式和地区划分

Fatty Amides Market, By Product Type (Erucamide, Oleamide, Stearamide, Behenamide), By Form (Powder, Beads, Micro-beads, Pastilles), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球脂肪酰胺市场规模估计为 4.286 亿美元,预计到 2032 年将达到 5.755 亿美元,2025 年至 2032 年的复合年增长率为 4.3%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 4.286亿美元
效能数据 2020-2024 预测期 2025-2032
预测期间:2025年至2032年的复合年增长率 4.30% 2032年价值预测 5.755亿美元
数字。 2025年脂肪酰胺各地区市场占有率(%)
脂肪酰胺市场-IMG1

近年来,由于脂肪酰胺在塑胶、橡胶和涂料等各种终端行业的应用不断扩大,全球脂肪酰胺市场经历了显着增长。脂肪酰胺在这些行业中主要用作润滑剂、流动增强剂和抗霜剂。脂肪酰胺具有热稳定性好、耐化学性佳、液体范围广等优良性能。此外,来自可再生植物和动物的脂肪酰胺有助于减少对石油衍生产品的依赖,从而促进市场成长。然而,原物料价格波动仍然是一个重大挑战。然而,随着人们对生物基化学品的永续性和益处的认识不断提高,脂肪酰胺製造商的机会也在不断扩大。脂肪酰胺,通常称为脂肪酸酰胺,是有机脂肪酸的衍生物,其中 OH 基团被 NH2(胺)基团取代。依产品类型,脂肪酰胺可分为Erucamide、油酰胺、硬脂酰胺和Behenamide。含有脂肪酰胺的产品以珠子、粉末状、有时是锭剂的形式出售。

市场动态

全球脂肪酰胺市场的成长受到塑胶和橡胶工业成长以及生物基化学品的普及导致的需求增加等因素的推动。脂肪酰胺主要用作塑胶和橡胶混合中的润滑剂、脱模剂和防黏剂。此外,对高性能产品的需求不断增长,推动了脂肪酰胺的消费。然而,棕榈油、椰子油、Tall oil原料的价格波动和供应不稳定带来了重大挑战。此外,有关石化产品排放的严格环境法规也抑制了市场的成长。同时,人们对永续性和生物化学品的偏好转变也带来了巨大的机会。领先的公司正在投资研发,以开发新的应用领域和环保生产技术。

研究的主要特点

  • 本报告对脂肪酰胺市场进行了详细分析,并给出了预测期(2025-2032)的市场规模和年复合成长率(CAGR),假设 2024 年为基准年。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 脂肪酰胺市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 脂肪酰胺市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
  • 个人护理行业的需求不断增长
  • 替代产品的可用性
  • 脂肪族酰胺的创新,适用于利基市场
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 合併、收购和合作

4. 脂肪酸酰胺市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 脂肪酰胺市场(依产品类型),2020 年至 2032 年

  • 介绍
  • Erucamide
  • 硬脂酰胺
  • Behenamide
  • 油酸酰胺

6. 脂肪酸酰胺市场(依形态),2020 年至 2032 年

  • 介绍
  • 粉末和珠子
  • 微珠
  • 锭剂

7. 脂肪酸酰胺市场(依地区划分),2020-2032

第八章 竞争态势

  • 公司简介
    • Lonza
    • Novartis International AG
    • BASF AG
    • SEQENS
    • Carbogen Amcis AG
    • Eli Lilly and Company
    • Teva Pharmaceutical Industries Ltd
    • Bristol-Myers Squibb
    • Pfizer Inc.
    • Roche Diagnostics
    • Boehringer Ingelheim
    • Merck & Co
    • Bayer AG
    • Ajinomoto Bio-Pharma Services
    • Cambrex Corporation
    • Minakem
    • Sanofi Aventis

第九章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI3486

Global Fatty Amides Market is estimated to be valued at USD 428.6 Mn in 2025 and is expected to reach USD 575.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 428.6 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.30% 2032 Value Projection: USD 575.5 Mn
Figure. Fatty Amides Market Share (%), By Region 2025
Fatty Amides Market - IMG1

The global fatty amides market has been witnessing significant growth in recent years driven by growing applications in various end-use industries such as plastics, rubber, coatings, and others. Fatty amides are mainly used as lubricants, flow promoters, and anti-blooming agents in these industries. They offer excellent properties such as outstanding thermal stability, chemical resistance, and wide liquid range. Additionally, fatty amides derived from renewable plant and animal sources help reduce dependency on petroleum-based products, thereby boosting the market growth. However, fluctuations in raw material prices remain a key challenge. But growing awareness about sustainability and benefits of bio-based chemicals is expanding opportunities for fatty amides manufacturers. Fatty amides, often termed fatty acid amides, are derivatives of organic fatty acids where an OH group is replaced by an NH2 (amine) group. Depending on the type of product, fatty amides are differentiated as erucamides, oleamides, stearamides, and behenamides. Products containing fatty amides are available in beads, powders, and sometimes also the pastilles form.

Market Dynamics:

The growth of the global fatty amides market is driven by factors such as increasing the demand from the thriving plastics and rubber industries and widespread adoption of bio-based chemicals. Fatty amides find major applications as lubricants, release agents, and anti-blocking agents in plastics and rubber formulations. Additionally, the growing need for high-performance products is propelling the consumption of fatty amides. However, fluctuations in prices and unreliable supply of raw materials such as palm oil, coconut oil, and tall oil pose a major challenge. Furthermore, strict environmental regulations regarding emissions from petrochemical-based products restrain the market growth. Meanwhile, shifting preference toward sustainability and bio-based chemicals presents significant opportunities. Leading players are investing in R&D to develop novel application areas and green production technologies.

Key Features of the Study:

  • This report provides an in-depth analysis of the fatty amides market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the fatty amides market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Haihang Industries Co. Ltd., Croda International Plc., PMC Biogenix Inc., Fine Organic Industries Pvt. Ltd., Nippon Fine Chemicals Co., Ltd., Kao Corporation, Italmatch Chemicals S.p.A., Sichuan Tianyu Oleochemical Co., Ltd., and Nippon Kasei Chemical Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The fatty amides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

  • Fatty Amides Market, By Product Type
    • Erucamides
    • Oleamides
    • Stearamides
    • Behenamides
  • Fatty Amides Market, By Form
    • Powder, Beads
    • Micro-beads
    • Pastilles
  • Fatty Amides Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Haihang Industries Co. Ltd.
    • Croda International Plc.
    • PMC Biogenix Inc.
    • Fine Organic Industries Pvt. Ltd.
    • Nippon Fine Chemicals Co., Ltd.
    • Kao Corporation
    • Italmatch Chemicals S.p.A.
    • Sichuan Tianyu Oleochemical Co., Ltd.
    • Nippon Kasei Chemical Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Fatty Amides Market, By Product Type
    • Fatty Amides Market, By Form
    • Fatty Amides Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand from the personal care industry
    • Restraints
  • Availability of substitutes
    • Opportunities
  • Innovation of fatty amides for niche Forms
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Fatty Amides Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Fatty Amides Market, By Product Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Erucamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Stearamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Behenamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Oleamide
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Fatty Amides Market, By Form , 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Powder, Beads
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Micro-beads
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Pastilles
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Fatty Amides Market , By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type , 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
        • South Africa
        • Central Africa
        • North Africa

8. Competitive Landscape

  • Company Profile
    • Lonza
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Novartis International AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • BASF AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • SEQENS
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Carbogen Amcis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bristol-Myers Squibb
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Roche Diagnostics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ajinomoto Bio-Pharma Services
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Cambrex Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Minakem
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi Aventis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
      • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us